Search

Background: The aim of this study was to compare the outcome of treatment for ovarian cancer patients who have been treated by gynecologist oncologists and patients who have been treated by general gynecologists or general surgeons. Methods: We enrolled in this cohort retrospective study all patients diagnosed with primary ovarian cancer in Vali-e-Asr Hospital, Tehran, Iran, between April 1999 and January 2005. A total 157 consecutive patients with ovarian cancer were available for analysis. Of these, 60 patients were treated by gynecologist oncologists and 95 by general gynecologists, and two patients were treated by general surgeons. Results: The number of patients who underwent optimal cytoreductive surgery (residual tumor

The article presents a study which determines whether optimum versus suboptimal cytoreductive surgery predicts cancer antigen 125 (CA125) levels two weeks after surgery. It states that cytoreductive surgery is a crucial component of primary treatment in patients with ovarian epithelial cancer (OEC). It notes that postoperative CA125 significantly decreased in two weeks after tumor cytoreduction in patients with OEC, but its regression did not differ to optimal or suboptimal groups.

The article presents a retrospective study on the effect of ovarian cancer surgery performed by general gynecologists (GGs) and gynecologist-oncologists (GOs) on the overall survival of cancer patients. The study involves patients who were diagnosed with primary ovarian cancer in Tehran, Iran. The results of the study suggest that patients can have greater disease-free survival chances if they will be referred to the gynecologist-oncologists for optimal treatment.